Safety and Efficacy of Intravesical Mitomycin C for Pre-Transurethral Resection of Bladder Tumors
Intravesical mitomycin C is commonly used in the treatment of bladder cancer immediately after transurethral resection of a tumor to reduce cancer recurrence and progression in non–muscle-invasive bladder cancer (NMIBC). However, lack of compliance is common due to associated complications such as chemical cystitis. Lee et al sought to assess the safety and efficacy of intravesical mitomycin C before transurethral resection of bladder tumors in patients with NMIBC. ...
Advertisement
Advertisement

Latest News

Advertisement
Advertisement
Editorial Advisory Board

Expert Interviews

Knowledge Hubs

Curated clinical content based on conditions, therapies, and technologies

Prostate Cancer
Prostate Cancer

The Uromigos

Podcasts hosted by Professors Thomas Powles, MD, and Brian Rini, MD

Conference Coverage

Live meeting highlights

Zachary BessetteASCO GU Symposium 2023 | January 19, 2023
Norman E Sharpless, MD, University of North Carolina School of Medicine, will present the keynote session.
Read More
Zachary BessetteASCO GU Symposium 2023 | January 19, 2023
Attendees will learn about different ways of managing renal cell carcinoma at all stages from research to practice.
Zachary BessetteASCO GU Symposium 2023 | January 19, 2023
Gerhardt Attard, MD, PhD, FRCP, will kick off the event with a session on advanced prostate cancer.
Zachary BessetteASCO GU Symposium 2023 | January 19, 2023
The event will feature world-class science and new and innovative findings in the study of GU malignancies.

Video Insights

Clinical discussions with experts in the field